Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jackson

Showing results (461-470 of 2,752) with videos related to

Pageof 276
Sort By:
Hospitals|May 5, 1986
Group purchasing marketing research: is it competitive?D J Vander Schaaf, E D Jackson
Clinical Medicine (London, England)|November 10, 2007
Inappropriate polypharmacy: reducing the burden of multiple medicationJames C Milton, Stephen H D Jackson
Lancet (London, England)|February 12, 1972
Dangerous fault in drip-setsR N Atherstone, D Jackson, E Pride
Heart & Lung : the Journal of Critical Care|January 1, 1978
Introduction to risk factors in coronary artery diseaseH D McIntosh, J Stamler, D Jackson
The American Journal of Medicine|May 17, 2002
Homocysteine and cardiovascular disease: current evidence and future prospectsArduino A Mangoni, Stephen H D Jackson
Eye (London, England)|January 1, 1993
The immunopharmacological actions of nedocromil sodium relative to the use of its 2% ophthalmic solutionA G Benbow, R Eady, D Jackson
Optics Letters|October 3, 2007
High-power and highly efficient Tm3+-doped silica fiber lasers pumped with diode lasers operating at 1150 nmStuart D Jackson, Frank Bugge, Götz Erbert
Optics Letters|November 21, 2007
High-power and highly efficient diode-cladding-pumped Ho3+-doped silica fiber lasersStuart D Jackson, Frank Bugge, Götz Erbert
Optics Letters|September 4, 2007
Directly diode-pumped holmium fiber lasersStuart D Jackson, F Bugge, G Erbert
British Journal of Clinical Pharmacology|May 4, 2006
The implications of a growing evidence base for drug use in elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarctionA A Mangoni, S H D Jackson
Pageof 276

Showing results (461-470 of 2,752) with videos related to

Sort By:
Pageof 276
Hospitals|May 5, 1986
Group purchasing marketing research: is it competitive?D J Vander Schaaf, E D Jackson
Clinical Medicine (London, England)|November 10, 2007
Inappropriate polypharmacy: reducing the burden of multiple medicationJames C Milton, Stephen H D Jackson
Lancet (London, England)|February 12, 1972
Dangerous fault in drip-setsR N Atherstone, D Jackson, E Pride
Heart & Lung : the Journal of Critical Care|January 1, 1978
Introduction to risk factors in coronary artery diseaseH D McIntosh, J Stamler, D Jackson
The American Journal of Medicine|May 17, 2002
Homocysteine and cardiovascular disease: current evidence and future prospectsArduino A Mangoni, Stephen H D Jackson
Eye (London, England)|January 1, 1993
The immunopharmacological actions of nedocromil sodium relative to the use of its 2% ophthalmic solutionA G Benbow, R Eady, D Jackson
Optics Letters|October 3, 2007
High-power and highly efficient Tm3+-doped silica fiber lasers pumped with diode lasers operating at 1150 nmStuart D Jackson, Frank Bugge, Götz Erbert
Optics Letters|November 21, 2007
High-power and highly efficient diode-cladding-pumped Ho3+-doped silica fiber lasersStuart D Jackson, Frank Bugge, Götz Erbert
Optics Letters|September 4, 2007
Directly diode-pumped holmium fiber lasersStuart D Jackson, F Bugge, G Erbert
British Journal of Clinical Pharmacology|May 4, 2006
The implications of a growing evidence base for drug use in elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarctionA A Mangoni, S H D Jackson
Pageof 276